New Delhi: After the expert panel of the drug regulator granted approval for the emergency use authorisation of Oxford AstraZeneca’s Covishield and Bharat Biotech’s Covaxin COVID-19 vaccines .
The Director of All India Institute of Medical Sciences (AIIMS) Dr. Randeep Guleria on Saturday told News 18 that India was ready for a mass rollout of the COVID-19 vaccine in the next 10 to 14 days.
“We will start the vaccination in a slow process. By that time more vaccines will be available,” he said.
Guleria stressed on the need for a proper time table to ensure crowd management when the vaccination process commences.
The he Subject Expert Committee of CDSCO had on Friday recommended emergency use authorisation of the AstraZeneca-Oxford vaccine and the Drugs Control Authority of India approval is expected on Sunday, January 3, 2021.
On Saturday the expert panel recommended that Bharat Biotech Covid-19 vaccine applicant Covaxin be approved for restricted emergency use in India.
Meanwhile, a dry run for the vaccination against COVID-19 was held across all states on Saturday in order to ensure smooth inoculation of the country’s population when the shots are rolled out.
Meanwhile, dry run for COVID-19 vaccination commenced in all States and UT governments across the country from Saturday with the objective to gear up for the roll-out of COVID-19 vaccine when it is ready.
According to Union Health Ministry, the objective is to “assess operational feasibility in the use of COVID Vaccine Intelligence Network (Co-WIN) application in a field environment, to test the linkages between planning and implementation and to identify the challenges and guide the way forward prior to actual implementation”.